Acta Med. 2005, 48: 145-148

https://doi.org/10.14712/18059694.2018.42

In vitro Inactivation of Rat Brain Acetylcholinesterase by DSP-4 and Its Derivatives OS-21 and OS-23 and Protective Activity of Tacrine (9-Amino-1,2,3,4-tetrahydroacridine)

Jiří Patočkaa,b, Daniel Junb,c, Kamil Kučab

aSouth Bohemia University, Faculty of Health and Social Studies, Department of Radiology and Toxicology, Czech Republic
bUniversity of Defence, Faculty of Military Health Sciences, Department of Toxicology, Czech Republic
cCharles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Pharmaceutical Botany and Ecology, Hradec Králové, Czech Republic

Received November 1, 2004
Accepted June 1, 2005

References

1. Abe K, Horiuchi M, Yoshimura K. Potentiation by DSP-4 of EEG slowing and memory impairment in basal forebrain-lesioned rats. Eur J Pharmacol 1997; 321:149–55. <https://doi.org/10.1016/S0014-2999(96)00934-X>
2. Baker BR. Design of active-site-directed irreversible enzyme inhibitors, NewYork, Wiley, 1967.
3. Belleau B, Tani H. A novel irreversible inhibitor of acetylcholinesterase specifically directed at the anionic binding site: structure-activity relationships. Mol Pharmacol 1966; 2:411–22.
4. Bielavský J. Analogues of 9-amino-1,2,3,4-tetrahydroacridine. Collect Czech Chem Commun 1977; 42:2802–8. <https://doi.org/10.1135/cccc19772802>
5. Dawson RM. Reversibility of the inhibition of acetylcholinesterase by tacrine. Neurosci Lett 1989; 100:227–30. <https://doi.org/10.1016/0304-3940(89)90689-7>
6. Giacobini E. Cholinesterase inhibitors for Alzheimer’s disease therapy: from tacrine to future applications. Neurochem Int 1998; 32:413–9. <https://doi.org/10.1016/S0197-0186(97)00124-1>
7. Harro J, Häidkind R, Harro M et al. Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment. Eur Neuropsychopharmacol 1999; 10:5–16. <https://doi.org/10.1016/S0924-977X(99)00043-7>
8. Huh N, Thompson CM. Enantioenriched N-(2-chloroalkyl)-3–acetoxypiperidines as potential cholinotoxic agents, synthesis and preliminary evidence for spirocyclic aziridinium formation. Tetrahedron 1995; 51:5935–50. <https://doi.org/10.1016/0040-4020(95)00285-G>
9. Kuča K, Kassa J. A comparison of the ability of a new bispyridinium oxime – 1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J Enzyme Inhib Med Chem 2003; 18:529–35. <https://doi.org/10.1080/14756360310001605552>
10. Kuča K, Patočka J. Reactivation of cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium-oximes. J Enzyme Inhib Med Chem 2004; 19:39–43. <https://doi.org/10.1080/1475636031000163850>
11. Liu J, Ho W, Lee NT, Carlier PR, Pang Y, Han Z. Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A-induced deficits in navigational memory in rats. Neurosci Lett 2000; 282:165–8. <https://doi.org/10.1016/S0304-3940(00)00905-8>
12. Palumaa P, Järv J. Alkylboronic acids accelerate affinity labelling of acetylcholinesterase with N,N-dimethyl-2–phenylaziridinium ion. Biochim Biophys Acta 1984; 748:35–9. <https://doi.org/10.1016/0167-4838(84)90169-9>
13. Patočka J, Bajgar J. Inhibition of acetylcholinesterase and butyrylcholinesterase by O-isopropyl-S-(2-diisopropylamionoethyl)-methylthiophosphonate. Collect Czech Chem Commun 1973; 41:3940–3. <https://doi.org/10.1135/cccc19733940>
14. Ricci A, Mancini M, Strocchi P, Bongrani S, Bronzetti E. Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: sensitivity to treatment with the monoamine oxidase-B inhibitor L-deprenyl. Drugs Exp Clin Res 1992; 18:163–71.
15. Ross SB, Johansson JG, Lindborg B, Dahlbom R. Tertiary N-(2–bromobenzyl)- N-haloalkylamines with adrenergic blocking action. Acta Pharm Suec 1973; 10:29–42.
16. Schuerger RJ, Balaban CD. N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) has differential efficacy for causing central noradrenergic lesions in two different rat strains: comparison between Long-Evans and Sprague-Dawley rats. J Neurosci Methods 1995; 58:95–101. <https://doi.org/10.1016/0165-0270(94)00163-B>
17. Sepp A, Järv J. Alkylation of acetylcholinesterase anionic centre with aziridinium ion accelerates the enzyme acylation step. Biochim Biophys Acta 1991; 1077:407–12. <https://doi.org/10.1016/0167-4838(91)90558-H>
18. Volkova RI, Kochetova LM. Inhibition of cholinesterases by aziridinium derivatives of polymethylene bischloroethylamines. Bioorg Khim 1983; 9:926–35.
19. Webb JL. Enzyme and metabolic inhibitors Vol. 1, New York, Academic Press, 1963.
20. Weis C, Kreienkamp HJ, Raba R, Pedak A, Aaviksaar A, Hucho F. Anionic subsites of the acetylcholinesterase from Torpedo californica: affinity labelling with the cationic reagent N,N-dimethyl-2–phenyl-aziridinium. EMBO J 1990; 9:3885–8. <https://doi.org/10.1002/j.1460-2075.1990.tb07607.x> <PubMed>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive